The R-CITY Project: A Collaborative Intervention With Teachers and Youth
Public ClinicalTrials.gov record NCT05585918. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
R-CITY: A Collaborative Intervention With Teachers and Youth
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
"R-CITY" refers to the Collaborative Intervention with Teachers and Youth to practice and apply the 4 "Rs" of social skills in the classroom - Recognizing, Responding, Relationships, and Resilience. R-CITY is a collaborative teacher- and youth-focused prevention intervention that offers student lessons to accompany the Second Step curriculum. The lessons are designed to create safe and positive learning environments for all. The R-CITY Project uses a school-level randomized controlled trial (RCT) design to test the integration of the Second Step program that the school district had been scaling up district wide with the R-CITY lessons. The purpose of the RCT is to determine the "value-added" of the Second Step program plus the new skill content compared to the Second Step alone in elementary and middle schools. Students in both conditions get access to the Second Step content, as an active control condition.
Study identification
- NCT ID
- NCT05585918
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 145 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 14, 2021
- Primary completion
- Jun 15, 2025
- Completion
- Nov 29, 2026
- Last update posted
- Jan 11, 2026
2021 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Shepard Pratt Health System | Towson | Maryland | 21204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05585918, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 11, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05585918 live on ClinicalTrials.gov.